CD73 acts as an immune-suppressor by stimulating the expression of DR5 via AMP-activated protein kinase, resulting in elevated immune-suppressive adenosine production in cancer stem cells and subsequent inhibition of the mammalian target of rapamycin [31,32,33]. This evidence concerns the gene TNFRSF10B and cancer.